Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study-Reference-Cited by-同舟云学术

Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study

Published:2019-04-01 Issue:1 Volume:5 Page:69-80
ISSN:2364-1754
Container-title:Pulmonary Therapy
language:en
Short-container-title:Pulm Ther

Author:

Hahn Beth^ORCID,Stanford Richard H.,Goolsby Hunter Alyssa,Essoi Breanna,White John,Ray Riju

Funder

GSK

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Respiratory Care

Link

http://link.springer.com/content/pdf/10.1007/s41030-019-0091-0.pdf

Reference37 articles.

1. Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, Sadatsafavi M. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2016;20(1):11–23.

2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2019 Report). http://goldcopd.org/gold-reports/ . Accessed 14 February 2019.

3. National Center for Health Statistics. Health, United States; 2016. https://www.cdc.gov/nchs/hus/index.htm . Accessed 28 September 2017.

4. Wheaton A, Cunningham T, Ford E, Croft J. Employment and activity limitations among adults with chronic obstructive pulmonary disease—United States, 2013. Morb Mortal Wkly Rep. 2015;64:289–95.

5. Lopez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of ensifentrine on dyspnea in patients with moderate-to-severe chronic obstructive pulmonary disease: pooled analysis of the ENHANCE trials;Expert Review of Respiratory Medicine;2024-08-08

2. Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-Linked Survey Study;Pulmonary Therapy;2019-08-07

3. Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study;Pulmonary Therapy;2019-08-06